Name
Isotopia Molecular Imaging
What We Do
✨Isotopia: Advancing Radiopharmaceutical Solutions with Reliable Lu-177 and Tb-161 Supply ✨
Isotopia USA, based in Westfield, Indiana, ensures a seamless, dependable supply of Lutetium-177 (Lu-177) for radiopharmaceutical therapies.
With a strong focus on overcoming logistical challenges, we streamline isotope delivery by eliminating customs delays, mitigating flight cancellations, and providing real-time tracking—ensuring on-time delivery every time.
Our state-of-the-art, GMP-compliant facility spans approximately 40,000 square feet and features aseptic manufacturing and sterility testing cleanrooms, advanced Quality Control (QC) and microbiology laboratories, and dedicated engineering spaces.
Starting July 2025, Isotopia USA will begin commercial-scale production of GMP-grade Lu-177 n.c.a., supporting process validation and clinical trials.
We are expanding to include Terbium-161 and other breakthrough isotopes, plus finished drug products for preclinical, clinical, and commercial use.
In Europe, we offer Isoprotrace, an advanced PSMA-11 radiolabelling kit for prostate cancer imaging, enabling efficient preparation of Gallium (68Ga) Gozetotide for I.V. injection.
*Isoprotrace is not yet FDA-approved in the USA.
**Authorized in the Netherlands, Germany, Denmark, Sweden, Malta, and the UK, with more EU approvals pending.
As a global nuclear medicine leader, Isotopia is committed to innovation, patient safety, and reliability, with long-term partnerships ensuring continuous isotope delivery worldwide.
Isotopia USA, based in Westfield, Indiana, ensures a seamless, dependable supply of Lutetium-177 (Lu-177) for radiopharmaceutical therapies.
With a strong focus on overcoming logistical challenges, we streamline isotope delivery by eliminating customs delays, mitigating flight cancellations, and providing real-time tracking—ensuring on-time delivery every time.
Our state-of-the-art, GMP-compliant facility spans approximately 40,000 square feet and features aseptic manufacturing and sterility testing cleanrooms, advanced Quality Control (QC) and microbiology laboratories, and dedicated engineering spaces.
Starting July 2025, Isotopia USA will begin commercial-scale production of GMP-grade Lu-177 n.c.a., supporting process validation and clinical trials.
We are expanding to include Terbium-161 and other breakthrough isotopes, plus finished drug products for preclinical, clinical, and commercial use.
In Europe, we offer Isoprotrace, an advanced PSMA-11 radiolabelling kit for prostate cancer imaging, enabling efficient preparation of Gallium (68Ga) Gozetotide for I.V. injection.
*Isoprotrace is not yet FDA-approved in the USA.
**Authorized in the Netherlands, Germany, Denmark, Sweden, Malta, and the UK, with more EU approvals pending.
As a global nuclear medicine leader, Isotopia is committed to innovation, patient safety, and reliability, with long-term partnerships ensuring continuous isotope delivery worldwide.
Founded
2007
Website
Categories
PET, PET/CT, Pharmaceuticals, Radioisotopes, Radiopharmaceuticals, Services, SPECT, SPECT/CT
Address
17075 Oak Ridge Rd, Westfield
Indianapolis, IN 46074
United States
Indianapolis, IN 46074
United States
Facebook
Twitter (X)
Listings
Relevance
